Number of Shares
3.00 Mil
Current Holdings Value*
$145.08 Mil
% of Portfolio
4.7%
Total Estimate Gain
$45.50 Mil
% of Total Estimate Gain
27.64%

Deep Track Capital, LP's Protagonist Therapeutics Inc Holding Summary

As of 2025-03-31, Deep Track Capital, LP held 3.00 Mil shares of Protagonist Therapeutics Inc(PTGX), totaling $145.08 Mil. This investment constitutes 4.7% of their stock portfolio, and Deep Track Capital, LP now holds 4.84% of the outstanding Protagonist Therapeutics Inc(PTGX) stock.

The initial trade took place in 2021Q4. And since then Deep Track Capital, LP has made 5 purchases of PTGX, at an average price of $34.17, for a total of 4.82 Mil shares. In addition, there have been 3 sales at an average price of $21.70 for 1.57 Mil shares. Based on historical transaction data and PTGX's current price of $54.19, Deep Track Capital, LP's estimated gain on his PTGX holdings is $45.50 Mil, reflecting a 27.64% gain to date.

Deep Track Capital, LP PTGX ($54.19) Holding Chart

Deep Track Capital, LP PTGX ($54.19) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1